The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

The researchers assessed prenatal exposures to smoking, alcohol, and stress (depression or anxiety) as well as maternal ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

The Washington State University Cowlitz County Extension SNAP-Ed program is putting on its third and final Farm to Family ...

Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes (ECHO) Program ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

The 70-page report from the Make America Healthy Again Commission targets the pharmaceutical and food industries for growing rates of childhood chronic disease.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Those aged 10-24 are confronting rising rates of chronic diseases, mental disorders and obesity, say experts calling for ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...